drugset / Trial / NCT04367935

Effect of Pentoxifylline on Endothelial Dysfunction in Patients With Acute Coronary Syndrome

NCT04367935

Phase 2/3 Completed 43 enrolled Ain Shams University
RandomizedParallel-groupSingle-blindTreatment

Summary

This study aims to investigate the effect of pentoxifylline administration on the status of endothelial function and oxidative stress biomarkers in patients with Acute Coronary Syndrome (ACS).

Timeline

Start
2021-01-01
Primary completion
2022-04-25
Completion
2022-04-25

Drugs

EvaluationDrugModalityDoseRoute
Comparator Pentoxifylline Small molecule 400 mg Oral